Event Date/Time: Sep 07, 2011
End Date/Time: Sep 09, 2011
The benefits to the patient, as well as the business opportunities a targeted therapy approach present are driving this change. The ADAPT 2011 Congress brings together senior executives and key strategic players from across Pharma, Diagnostic, Clinical and Informatics to work together to shape the future of personalized medicine towards a targeted approach. Case studies, discussion groups, short courses and technology highlights will explore the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market.